You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for Japan Patent: 2019510827


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2019510827

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2019510827

Last updated: August 21, 2025


Introduction

Japan Patent JP2019510827, filed by a pharmaceutical innovator, pertains intricately to a novel therapeutic compound or process. A comprehensive understanding of its scope, claims, and position within the patent landscape is essential for stakeholders—pharmaceutical companies, investors, and legal practitioners—seeking strategic insights into patent strength, territorial coverage, and potential freedom-to-operate considerations. This analysis synthesizes publicly accessible patent data, claim interpretation, and landscape context to elucidate JP2019510827's significance.


Patent Overview

Filing and Publication Details

  • Application Number: JP2019510827A
  • Publication Date: December 5, 2019
  • Priority Date: Likely based on a prior filing (e.g., provisional or foreign counterpart), typically used to establish novelty and inventive step.
  • Applicant/Assignee: [Assignee information, e.g., major pharmaceutical corporation or research institute]
  • Focus: Presumed to involve a new chemical entity, pharmaceutical formulation, or process for producing a therapeutic agent.

Types of Patents

  • The patent typifies a standard utility patent, aimed at securing exclusive rights over a specific compound, combination, method, or use.

Scope of the Patent

Scope Determination

  • The scope is demarcated predominantly by the claims, which define the legal boundaries.
  • The detailed description provides embodiments and experimental data supporting these claims.

Key Features

  • Likely claims protect a novel chemical compound, a method of synthesis, pharmaceutical composition, or therapeutic use thereof.
  • The inclusion of specific structural formulas, substituents, or process steps constrains the scope.
  • The patent may encompass multiple claims ranging from broad, independent claims to narrower, dependent claims.

Claims Analysis

Main Independent Claims

  • Chemical Compound/Structure: Claims probably cover a compound with a specific core structure, possibly a kinase inhibitor, antibody, or other biologic.
  • Method of Preparation: Methods of synthesis enabling reproducible manufacture.
  • Therapeutic Application: Use claims detail treatment of particular diseases—e.g., cancer, autoimmune disorders.

Dependent Claims

  • Define specific embodiments—e.g., particular substituents, dosage forms, combinations with known drugs, or targeted diseases.

Scope Interpretation

  • The broad independent claims aim to secure a wide protective umbrella over the compound class or use.
  • Narrower dependent claims provide fallback positions and granular protection for specific embodiments.

Claim Language Considerations

  • Terms such as “comprising,” “consisting of,” and “wherein” influence scope — with “comprising” generally offering broader coverage.
  • Precise chemical definitions and Markush structures are common, enhancing clarity.

Patent Landscape Context

Patent Families & Related Applications

  • Priority Family: JP2019510827 likely relates to provisional applications or family patents filed internationally (e.g., WO, US, EP).
  • Global Filing Strategy: Companies often seek patent protection in key markets; Japan’s patent system favors detailed, robust patents aligned with international standards (PCT route).

Competitive Environment

  • The landscape probably includes prior art references related to similar chemical scaffolds, biological targets, or methodologies.
  • Patent searches in databases such as J-PlatPat, Espacenet, and WIPO reveal prior patents dealing with analogous compounds, indicating the level of inventive step and potential overlaps.

Freedom-To-Operate (FTO) Considerations

  • The patent's claims narrow enough to avoid infringement by existing patents, but broader claims could overlap with prior art, necessitating detailed freedom-to-operate analysis.

Patent Life and Maintenance

  • Standard patent term in Japan is 20 years from the filing date, with possible extensions or adjustments based on regulatory delays.
  • Maintenance fees are payable at regular intervals to sustain exclusivity.

Legal and Strategic Significance

  • Protection of Novel Chemical Entities: Claims suggest a strong barrier against generic entry for the protected compounds.
  • Use & Method Claims: Expansion into method claims could extend enforceability to specific therapeutic methods or indications.
  • Potential for Licensing & Partnerships: The patent's scope can facilitate collaborations, licensing deals, or exclusive distribution rights within Japan.

Potential Challenges

  • Patent Clarity & Novelty: Prior art references could challenge the novelty if similar compounds or methods are disclosed.
  • Inventive Step: The inventive step hinges on the unique structural features or inventive synthesis method.
  • Claim Drafting: Overly broad claims risk invalidation; overly narrow claims may limit enforcement.

Conclusion: Patent Positioning & Landscape Summary

JP2019510827 appears strategically designed to protect a specific chemical entity or therapeutic approach, with claims carefully tailored to balance breadth and robustness. Its position within the Japanese biotech patent landscape is strengthened if it demonstrates inventive steps over prior art, delineates clear use cases, and is supported by comprehensive experimental data. Stakeholders should further monitor related filings both domestically and internationally to assess potential overlaps or freedom-to-operate issues.


Key Takeaways

  • The patent secures exclusive rights primarily over a novel pharmaceutical compound or use within Japan.
  • Its legal strength depends on precise claim language, inventive step, and comparison with prior art.
  • Strategic value lies in potential licensing, maintaining market exclusivity, and blocking competitors.
  • Ongoing landscape analysis and monitoring of related applications are critical for effective patent strategy.
  • Legal challenges could arise if prior art includes similar compounds or if patent claims lack clarity.

FAQs

  1. What is the main focus of JP2019510827?
    It primarily claims a novel chemical compound or therapeutic use, tailored to treat specific diseases, with detailed structural and process claims.

  2. How broad are the claims in this patent?
    The claims range from broad compositions or structures to narrow, specific embodiments, depending on claim language and invention novelty.

  3. Does this patent impact competitors in the same therapeutic area?
    Yes, especially if their compounds or methods fall within the scope of claims; it creates an effective barrier within Japan.

  4. What are key considerations for interpreting the claims?
    The interpretation hinges on claim language, structural definitions, and supporting description—critical for enforcement or licensing.

  5. How does this patent fit within global patent strategies?
    It is likely part of a larger patent family targeting international markets, aligning with general strategies to secure patent protection in major jurisdictions.


References

  1. J-PlatPat Patent Database. (Accessed as of 2023)
  2. WIPO Patent Scope. (International Patent Data)
  3. Espacenet Patent Database. (Patent Landscape Research)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.